[KYMR] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
31-Oct-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -48.56%
YoY- -18.20%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 3,741 25,650 10,287 47,885 4,728 16,513 9,466 -46.05%
PBT -62,487 -42,062 -48,557 -14,368 -52,867 -38,799 -40,928 32.48%
Tax 0 0 39 4,996 -895 4,632 -4,343 -
NP -62,487 -42,062 -48,557 -14,368 -52,867 -38,799 -36,585 42.74%
Tax Rate - - - - - - - -
Total Cost 66,228 67,712 58,844 62,253 57,595 55,312 46,051 27.32%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -1,670.33 -163.98 -472.02 -30.01 -1,118.17 -234.96 -386.49 164.61%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.82 -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 19.15%
EPS Diluted -0.82 -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 19.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.